FDA MedWatch - Class 1 recall of Becton Dickinson ProbeTec ET Urine Processsing Kit
Featured Replies
This topic is now closed to further replies.
Currently Reading 0
- No registered users viewing this page.
A better way to browse. Learn more.
A full-screen app on your home screen with push notifications, badges and more.
MedWatch - The FDA Safety Information and Adverse Event Reporting Program
FDA and Becton Dickinson notified healthcare professionals of a Class 1
recall of the ProbeTec ET Urine Processing Kit, designed to aid in testing
male and female urine specimens for Chlamydia and gonorrhea. This laboratory
test may cause indeterminate and false negative clinical results which could
lead to the patient not receiving treatment. Untreated infection could
result in worsening infections, further disease transmission, pelvic
inflammatory disease, infertility, ectopic pregnancy and other sequellae.
Read the complete MedWatch 2005 safety summary, including links to the FDA
Recall notice, at
http://www.fda.gov/medwatch/SAFETY/2005/safety05.htm#probetec